Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
Is a
Allocation Type
NA
0
Trial Collaborator
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
Viralym-A
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Last Updated
July 23, 2018
0
Masking Type
None (Open Label)
0
Primary Completion Date
2018
0
Trial Recruitment Size
0
0
Trial Sponsor
Clinical Trial Start Date
December 7, 2017
0
Study Completion Date
2019
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase I Study Using Most Closely HLA-matched Adenovirus-specific T Lymphocytes for the Treatment of Adenovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-A)
0
Official Website
Find more entities like Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.